FR2768928B1 - Liposomes comprenant de la fha et leurs utilisations a titre de vaccins, et utilisation de la fha pour la stimulation de reponses immunitaires - Google Patents

Liposomes comprenant de la fha et leurs utilisations a titre de vaccins, et utilisation de la fha pour la stimulation de reponses immunitaires

Info

Publication number
FR2768928B1
FR2768928B1 FR9812503A FR9812503A FR2768928B1 FR 2768928 B1 FR2768928 B1 FR 2768928B1 FR 9812503 A FR9812503 A FR 9812503A FR 9812503 A FR9812503 A FR 9812503A FR 2768928 B1 FR2768928 B1 FR 2768928B1
Authority
FR
France
Prior art keywords
fha
liposomes
stimulation
immune responses
vaccine uses
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR9812503A
Other languages
English (en)
Other versions
FR2768928A1 (fr
Inventor
Nathalie Mielcarek
Camille Locht
Gilles Riveau
Godefroy Odile Poulain
Andre Capron
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut Pasteur de Lille
Original Assignee
Institut Pasteur de Lille
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institut Pasteur de Lille filed Critical Institut Pasteur de Lille
Priority to FR9812503A priority Critical patent/FR2768928B1/fr
Publication of FR2768928A1 publication Critical patent/FR2768928A1/fr
Application granted granted Critical
Publication of FR2768928B1 publication Critical patent/FR2768928B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/099—Bordetella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55516—Proteins; Peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Dispersion Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
FR9812503A 1998-10-06 1998-10-06 Liposomes comprenant de la fha et leurs utilisations a titre de vaccins, et utilisation de la fha pour la stimulation de reponses immunitaires Expired - Fee Related FR2768928B1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR9812503A FR2768928B1 (fr) 1998-10-06 1998-10-06 Liposomes comprenant de la fha et leurs utilisations a titre de vaccins, et utilisation de la fha pour la stimulation de reponses immunitaires

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9812503A FR2768928B1 (fr) 1998-10-06 1998-10-06 Liposomes comprenant de la fha et leurs utilisations a titre de vaccins, et utilisation de la fha pour la stimulation de reponses immunitaires

Publications (2)

Publication Number Publication Date
FR2768928A1 FR2768928A1 (fr) 1999-04-02
FR2768928B1 true FR2768928B1 (fr) 2002-06-07

Family

ID=9531249

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9812503A Expired - Fee Related FR2768928B1 (fr) 1998-10-06 1998-10-06 Liposomes comprenant de la fha et leurs utilisations a titre de vaccins, et utilisation de la fha pour la stimulation de reponses immunitaires

Country Status (1)

Country Link
FR (1) FR2768928B1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101199843B (zh) * 2007-07-25 2012-11-28 中国人民解放军第三军医大学 一种百日咳基因工程融合亚单位疫苗及其制备方法

Also Published As

Publication number Publication date
FR2768928A1 (fr) 1999-04-02

Similar Documents

Publication Publication Date Title
CY2009014I1 (el) Εμβολιο εναντι αντιγονων απο βακτηριδια
NO996133D0 (no) Olje-i-vann-vaksinesammensetninger
DK2241616T3 (da) Immunitetsforbedrende mælkesyrebakterier
DK1210113T3 (da) Kombinerede vaccinepræparater
ATE413188T1 (de) Menschliche papillomavirus impfstoff- formulierungen
MX9703505A (es) Adyuvante para composicion vaccinea.
NO20003303D0 (no) Vaksine
PL341818A1 (en) Hvi-1 tat or its derivatives for prophylactic or therapeutic vaccination
DK0918059T3 (da) Susbstituerede imidazolidinderivater, deres fremstilling og anvendelse samt farmaceutiske præparater indeholdende disse derivater
FR2796643B1 (fr) Derives de 2-arylimino-2, 3-dihydrothiazoles, leurs procedes de preparation et leur utilisation therapeutique
DE60028390D1 (de) Methoden um rotavirusvarianten zu trennen und lebender attenuierter rotavirus impfstoff
DE69629457D1 (de) Impfstoff in gelform
FR2768928B1 (fr) Liposomes comprenant de la fha et leurs utilisations a titre de vaccins, et utilisation de la fha pour la stimulation de reponses immunitaires
DK0835254T3 (da) Oxazolidinonderivater, deres fremstilling og deres terapeutiske anvendelse
FR2715304B1 (fr) Vaccin anti-allergique.
GB9611673D0 (en) Meningococcal vaccine
FR2748476B1 (fr) Complexe immunogene, son utilisation, son procede de preparation et vaccin le contenant
GB9900976D0 (en) Vaccine preparations
BR9807299B1 (pt) vacina contra bursite infecciosa.
NL300165I1 (nl) Babesiavaccine.
HUT72403A (en) Babesia vaccine
GB9702990D0 (en) Virus vaccine
GB9423663D0 (en) Viral preparations, immunogens, and vaccines
DE29722856U1 (de) Wirbelsäulen-Therapieliege
BR9505224A (pt) Saco para isolamento ventricular

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20140630